Lachlan Brown

Stock Analyst at William Blair

(2.52)
# 2,258
Out of 5,154 analysts
11
Total ratings
55.56%
Success rate
15.33%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $28.96
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $147.00
Upside: +36.05%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $36.17
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.68
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $10.33
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $442.30
Upside: +35.65%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $299.84
Upside: +16.73%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $20.15
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $71.54
Upside: +25.80%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $64.05
Upside: +243.48%